<DOC>
	<DOCNO>NCT00626340</DOCNO>
	<brief_summary>The purpose study measure cortical gama-aminobutyric acid level ( GABA ) level menopausal woman major depressive disorder healthy subject use nuclear magnetic resonance spectroscopy ( MRS ) . Measurements compare 1 ) menopausal healthy subject estrogen replacement , fourteen day medroxyprogesterone administration ; 2 ) depress menopausal subject treatment depression antidepressant alone , estrogen alone antidepressant plus estrogen . Cortical GABA level correlate plasma GABA neurosteroid level . Neurosteroids measure include progesterone , allopregnanalone , pregnenolone , pregnenolone sulfate .</brief_summary>
	<brief_title>Brain Imaging Study Menopausal Women With Without Major Depressive Disorder</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Fluoxetine</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<criteria>Inclusion criterion Depressed Patients : Aged 4070 year able give voluntary write informed consent . Meet DSMIV criterion major depression base structured clinical interview ( SCID ) . Have medical contraindication estrogen . ( This include write documentation recent normal gynecological evaluation mammogram ) . A minimum score 25 25item Hamilton Depression Rating Scale initial baseline rating show improvement oneweek observation period . Perimenopausal subject irregular menses either &lt; 21 day &gt; 35 day previous six month one year . Postmenopausal subject menstrual cycle hormone therapy least one year serum FSH &gt; 45 . Exclusion criterion : Meeting DSMIV Axis I disorder . A history serious medical neurological illness , include ( limit ) major cardiovascular disease , severe hypertension , intracranial mass lesion , seizure disorder , severe hepatic renal disease , unstable endocrine metabolic disease , unstable hematologic disease . A history moderate severe endometriosis ; milder case require subject 's Gynecologists permission participate . Use anticonvulsants benzodiazepine within last month . Use psychotropic medication last week ( except state ) . Use alcohol within last month . Current pregnancy ( perimenopausal subject ) . Positive urine drug screen . Metallic implant . Inclusion Criteria Healthy Subjects : No DSMIV psychiatric substance abuse diagnosis structure diagnostic interview ( SCID ) . No medical contraindication estrogen ( include write documentation recent normal gynecological exam mammogram ) . Matched depressed patient age menopausal status . Have menstrual cycle hormone therapy least one year irregular menses either &lt; 21 day 35 day previous six month one year . Exclusion Criteria Healthy Subjects : Medical , neurologic cerebrovascular disorder ( CVA , seizure disorder , etc. ) . Evidence substance use urine toxicology screen do upon recruitment . Current treatment psychoactive medication . Diabetes control mean diet . Use alcohol within last month . Implanted metallic device . Positive urine drug screen .</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>menopause</keyword>
	<keyword>woman</keyword>
	<keyword>major depressive disorder</keyword>
	<keyword>Magnetic Resonance Spectroscopy</keyword>
</DOC>